Loading...

Pulse Biosciences, Inc.

PLSENASDAQ
Healthcare
Medical - Instruments & Supplies
$14.73
$0.02(0.14%)

Pulse Biosciences, Inc. (PLSE) Company Profile & Overview

Explore Pulse Biosciences, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Pulse Biosciences, Inc. (PLSE) Company Profile & Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

SectorHealthcare
IndustryMedical - Instruments & Supplies
CEOPaul Arthur LaViolette

Contact Information

510 906 4600
3957 Point Eden Way, Miami, CA, 94545

Company Facts

75 Employees
IPO DateMay 18, 2016
CountryUS
Actively Trading

Frequently Asked Questions

;